drugset / Trial / NCT02264184

Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

NCT02264184

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to investigate the effect of CYP2D6 inhibition by paroxetine on the single oral dose pharmacokinetics of tamsulosin and to investigate the effect on safety and tolerability

Timeline

Start
2008-09
Primary completion
2008-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule
Subject Tamsulosin Other / unclassified Oral

Indications

No indication recorded.